世界经济论坛-加速全球向生物经济转型：政策的战略作用（英）

Accelerating the Global Transition to a Bio-based Economy: The Strategic Role of PolicyW H I T E P A P E RS E P T E M B E R 2 0 2 4Images: Getty Images© 2024 World Economic Forum. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, including photocopying and recording, or by any information storage and retrieval system.Disclaimer This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum, nor the entirety of its Members, Partners or other stakeholders.ContentsForewordExecutive summaryIntroduction1 Streamlining regulation: The role of policy in unlocking the promise of genomics and human health2 Scaling sustainable alternatives: The role of policy in delivering sustainable alternatives for hard-to-abate industries3 Commercialization and adoption: The role of policy in shaping sustainable food and agricultural systemsConclusionContributorsEndnotes34561015202122Accelerating the Global Transition to a Bio-based Economy: The Strategic Role of Policy 2ForewordThe blending of the digital, physical and biological worlds is reshaping society. Policy is at the forefront: for decades, policy has been structuring the responsible transition of biology into a commercial technology. As tools evolve to more reliably harness biology, the interplay between policy and innovation has never been more important – to safeguard the human-centred transition to a resilient, bio-based economy. Although not always recognized, this interplay is not new: effective policies have propelled groundbreaking technologies from the laboratory to widespread societal use for centuries. Without the foundational support of well-crafted policies, even the most promising innovations risk stagnation or failing to reach those who would benefit the most. As the journey to a bio-based economy advances, policy will be key in fostering resilient and equitable economies through the commercial application of bio-innovation.At the core of this transition, the recipe for success, is biology. Bio-innovation has provided us with rapid responses to human health crises and solutions to reverse diminishing agricultural productivity due to climate change. Even Ozempic, the diabetes and weight-loss drug, is a product of biomanufacturing. Beyond human health and agricultural applications, bio-based approaches have also provided early-stage alternatives for many daily necessities historically associated with polluting or high-emissions production. In addition to technological progress, policy is the key driver that will define the magnitude of the impact that bio-innovation is capable of achieving. As we build a future where bio-innovati